Marissa Roldan

Title: Marissa Roldan: Innovator in Lipid Accumulation Technologies

Introduction

Marissa Roldan is a prominent inventor based in Palmerston North, New Zealand. She has made significant contributions to the field of biotechnology, particularly in the area of lipid accumulation. With a total of four patents to her name, Roldan's work focuses on enhancing the properties of acyltransferase proteins.

Latest Patents

Roldan's latest patents include "Enhanced acyltransferase polynucleotides, polypeptides and methods of use." This invention provides modified DGAT1 proteins that exhibit enhanced activity without reduced protein accumulation when expressed in cells. These modified proteins can be utilized to increase cellular lipid accumulation and modify the cellular lipid profile. Another notable patent is "Acyltransferase polynucleotides, polypeptides and methods of use," which introduces a novel DGAT1 protein with improved properties over known DGAT proteins, particularly those derived from plants. The expression of this novel protein in cells results in a higher level of lipid accumulation compared to other tested plant DGAT1 proteins.

Career Highlights

Throughout her career, Marissa Roldan has worked with reputable organizations such as AgResearch Limited and the National Research Council of Canada. Her research has significantly advanced the understanding of lipid metabolism and its applications in biotechnology.

Collaborations

Roldan has collaborated with notable colleagues, including Nicholas John Roberts and Somrutai Winichayakul. These partnerships have contributed to her innovative research and the successful development of her patented technologies.

Conclusion

Marissa Roldan is a trailblazer in the field of biotechnology, with her inventions paving the way for advancements in lipid accumulation technologies. Her work continues to influence the industry and inspire future innovations.